TickerFactsScreenerDevelopers

KalVista Pharmaceuticals, Inc. (KALV) — Net Income

Annual figures by fiscal year, from SEC filings.

2013: -$5.68M2014: -$13.36M2015: -$24.85M2016: -$11.44M2017: -$18.60M2018: -$15.80M2019: -$20.82M2020: -$29.12M2021: -$46.24M2022: -$82.34M2023: -$92.90M2024: -$126.60M2025: -$183.40M-$183.40M
2013Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$183.40M-44.9%
2024-$126.60M-36.3%
2023-$92.90M-12.8%
2022-$82.34M-78.1%
2021-$46.24M-58.8%
2020-$29.12M-39.9%
2019-$20.82M-31.7%
2018-$15.80M+15.0%
2017-$18.60M-62.7%
2016-$11.44M+54.0%
2015-$24.85M-86.0%
2014-$13.36M-135.3%
2013-$5.68M—